Comprehensive pharmacogenetic tests are offered for genes such as CYP2C9, CYP2C19, CYP2D6 and 5-HTT, which are needed to optimize the use of warfarin, clopidogrel and various commonly prescribed antipsychotic drugs.
These molecular genetic analyses help physicians adjust doses and choose the most effective treatments, reducing the risks of hypersensitivity, treatment resistance and significant side effects.